Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
(and what would stop therapy) A reputable clinician wont oversell AOD-9604
People with Digestive or Autoimmune Conditions Conditions such as Crohns disease, celiac disease, ulcerative colitis, and other gastrointestinal disorders can significantly impair the bodys ability to absorb nutrients, including B12
Research published in Endocrinology demonstrated that both human growth hormone and AOD-9604 significantly increased the expression of beta-3 adrenergic receptors in adipose tissue, restoring suppressed receptor levels in obese animal models to match those in lean controls
Less Risk of Hormonal Disruption Unlike HGH therapy, AOD9604 doesnt significantly affect IGF1 levels or alter broader endocrine function
US$ 25.72
US$ 24.72
US$ 26.86
US$ 23.78
